ZBTB8B
gene geneOn this page
Also known as RP1-27O5.1DKFZp547H154ZNF916B
Summary
ZBTB8B (zinc finger and BTB domain containing 8B, HGNC:37057) is a protein-coding gene on chromosome 1p35.1, encoding Zinc finger and BTB domain-containing protein 8B (Q8NAP8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific. Predicted to be involved in regulation of transcription by RNA polymerase II. Located in cytosol and nucleoplasm.
Source: NCBI Gene 728116 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 70 total
- MANE Select transcript:
NM_001145720
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37057 |
| Approved symbol | ZBTB8B |
| Name | zinc finger and BTB domain containing 8B |
| Location | 1p35.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP1-27O5.1, DKFZp547H154, ZNF916B |
| Ensembl gene | ENSG00000273274 |
| Ensembl biotype | protein_coding |
| Entrez | 728116 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 4 protein_coding
ENST00000609129, ENST00000930949, ENST00000930950, ENST00000930951
RefSeq mRNA: 1 — MANE Select: NM_001145720
NM_001145720
CCDS: CCDS44104
Canonical transcript exons
ENST00000609129 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002172003 | 32465072 | 32465105 |
| ENSE00003564881 | 32470584 | 32471615 |
| ENSE00003625423 | 32480891 | 32481069 |
| ENSE00003702530 | 32485101 | 32496686 |
Expression profiles
Bgee: expression breadth broad, 46 present calls, max score 76.54.
FANTOM5 (CAGE): breadth broad, TPM avg 0.5457 / max 54.2742, expressed in 290 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1990 | 0.5457 | 290 |
Top tissues by expression
224 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 76.54 | gold quality |
| buccal mucosa cell | CL:0002336 | 68.83 | gold quality |
| ventricular zone | UBERON:0003053 | 67.42 | gold quality |
| ganglionic eminence | UBERON:0004023 | 65.22 | gold quality |
| cortical plate | UBERON:0005343 | 65.21 | gold quality |
| hypothalamus | UBERON:0001898 | 55.47 | gold quality |
| skin of hip | UBERON:0001554 | 55.33 | silver quality |
| amygdala | UBERON:0001876 | 54.05 | gold quality |
| colonic epithelium | UBERON:0000397 | 53.04 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.39 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 51.81 | gold quality |
| bone marrow cell | CL:0002092 | 49.58 | gold quality |
| sural nerve | UBERON:0015488 | 49.54 | gold quality |
| substantia nigra | UBERON:0002038 | 49.18 | gold quality |
| neocortex | UBERON:0001950 | 48.99 | gold quality |
| stromal cell of endometrium | CL:0002255 | 48.75 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 48.32 | gold quality |
| temporal lobe | UBERON:0001871 | 48.14 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 48.08 | gold quality |
| midbrain | UBERON:0001891 | 48.04 | gold quality |
| frontal cortex | UBERON:0001870 | 47.93 | silver quality |
| pituitary gland | UBERON:0000007 | 47.80 | gold quality |
| adenohypophysis | UBERON:0002196 | 47.79 | gold quality |
| cerebral cortex | UBERON:0000956 | 47.70 | gold quality |
| islet of Langerhans | UBERON:0000006 | 47.15 | silver quality |
| forebrain | UBERON:0001890 | 46.92 | gold quality |
| endometrium | UBERON:0001295 | 46.75 | gold quality |
| brain | UBERON:0000955 | 46.66 | gold quality |
| Ammon’s horn | UBERON:0001954 | 46.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 46.21 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.11 |
| E-GEOD-86618 | no | 41.19 |
| E-MTAB-6678 | no | 3.68 |
Regulation
Is transcription factor: yes
Downstream targets (CollecTRI)
2 targets.
| Target | Regulation |
|---|---|
| CDKN1A | Unknown |
| NOTCH1 |
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2579.1 | ZBTB8B | Other factors with up to three adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
97 targeting ZBTB8B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-23B-5P | 99.98 | 66.07 | 587 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-23A-5P | 99.94 | 65.39 | 468 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zbtb8b | ENSMUSG00000048485 |
| rattus_norvegicus | Zbtb8b | ENSRNOG00000026898 |
Paralogs (5): ZBTB8A (ENSG00000160062), ZBTB10 (ENSG00000205189), ZBTB9 (ENSG00000213588), ZBTB22 (ENSG00000236104), C17orf113 (ENSG00000267221)
Protein
Protein identifiers
Zinc finger and BTB domain-containing protein 8B — Q8NAP8 (reviewed: Q8NAP8)
All UniProt accessions (1): Q8NAP8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NAP8-1 | 1 | yes |
| Q8NAP8-2 | 2 |
RefSeq proteins (1): NP_001139192* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050457 | ZnFinger_BTB_dom_contain | Family |
Pfam: PF00651, PF13465
UniProt features (10 total): zinc finger region 2, region of interest 2, compositionally biased region 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NAP8-F1 | 58.37 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 52 (showing top):
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, chr1p35, QI_HYPOXIA, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, LMTK3_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF22_TARGET_GENES, ZSCAN21_TARGET_GENES, MIR4795_3P, MIR4500, MIR4668_3P, LET_7B_5P, LET_7A_5P_LET_7C_5P_LET_7E_5P, LET_7I_5P
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (5): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (4): chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654), cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| chromosome | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cytoplasm | 1 |
Protein interactions and networks
STRING
416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZBTB8B | GRIFIN | A4D1Z8 | 527 |
| ZBTB8B | MOCS2 | O96007 | 484 |
| ZBTB8B | MBOAT1 | Q6ZNC8 | 475 |
| ZBTB8B | DHX32 | Q7L7V1 | 470 |
| ZBTB8B | TMEM40 | Q8WWA1 | 434 |
| ZBTB8B | MINDY4B | A8MYZ0 | 432 |
| ZBTB8B | GPRC5B | Q9NZH0 | 419 |
| ZBTB8B | NPL | Q9BXD5 | 418 |
| ZBTB8B | ACSF2 | Q96CM8 | 417 |
| ZBTB8B | TSPAN11 | A1L157 | 404 |
| ZBTB8B | HMGN3 | Q15651 | 404 |
| ZBTB8B | MAB21L1 | Q13394 | 348 |
| ZBTB8B | THAP4 | Q8WY91 | 340 |
| ZBTB8B | SLC22A14 | Q9Y267 | 325 |
| ZBTB8B | SLC35D1 | Q9NTN3 | 323 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MATCAP1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGTA | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDC7 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB8B | LMO3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB8B | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB8B | SPATC1L | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB8B | MORF4L1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZBTB8B | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCAS2 | INPPL1 | psi-mi:“MI:0914”(association) | 0.350 |
| MATCAP1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| SGTA | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| CDC7 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| LMO3 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTAQ1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| LMO1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| SPATC1L | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| MORF4L1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBQLN1 | ZBTB8B | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (17): ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Two-hybrid), ZBTB8B (Affinity Capture-MS), ZBTB8B (Positive Genetic), ZBTB8B (Co-fractionation), ZBTB8B (Co-fractionation), ZBTB8B (Co-fractionation), ZBTB8B (Co-fractionation)
ESM2 similar proteins: A0JN76, A1L2U9, B1WAZ8, B1WBU4, O15060, O35260, O43298, O93567, P14404, P41182, P41183, Q05516, Q0IH98, Q0IJ29, Q0P4X6, Q0V8G8, Q0VCJ6, Q15916, Q1L8W0, Q3B725, Q3SWU4, Q5TC79, Q5ZM39, Q6NRM8, Q6P882, Q6YND2, Q7TQG0, Q7TSZ8, Q7ZWZ4, Q801P1, Q80X44, Q86UZ6, Q8BID6, Q8CII0, Q8K088, Q8K0L9, Q8N680, Q8NAP8, Q8NCN2, Q8NCP5
Diamond homologs: A0JN76, A1L2U9, A1YEX3, A1YPR0, A2AAX3, B1WAZ8, B1WBS3, B1WBU4, B2RXF5, D3ZA50, O14867, O15062, O15156, O15209, O43167, O43298, O43829, O88282, O88939, O93567, O95365, P24278, P41182, P41183, P52739, P97302, P97303, Q08376, Q0IH98, Q0IJ29, Q0P4X6, Q0VCJ6, Q13105, Q14526, Q1H9T6, Q1L8W0, Q2T9Z7, Q3B725, Q3B7N9, Q3SWU4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
70 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 66 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1086 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:32465103:AAG:A | donor_loss | 1.0000 |
| 1:32481066:GAGT:G | donor_gain | 1.0000 |
| 1:32481067:AGTGT:A | donor_loss | 1.0000 |
| 1:32481068:GT:G | donor_gain | 1.0000 |
| 1:32481069:TG:T | donor_loss | 1.0000 |
| 1:32481070:G:C | donor_loss | 1.0000 |
| 1:32481070:G:GG | donor_gain | 1.0000 |
| 1:32481071:T:TC | donor_loss | 1.0000 |
| 1:32485328:GTCGG:G | donor_gain | 1.0000 |
| 1:32485411:T:G | donor_gain | 1.0000 |
| 1:32465104:AGGTG:A | donor_loss | 0.9900 |
| 1:32465105:GGT:G | donor_loss | 0.9900 |
| 1:32480944:A:AG | acceptor_gain | 0.9900 |
| 1:32480945:C:G | acceptor_gain | 0.9900 |
| 1:32481065:TGAGT:T | donor_gain | 0.9900 |
| 1:32481066:GAGTG:G | donor_gain | 0.9900 |
| 1:32481067:AGT:A | donor_gain | 0.9900 |
| 1:32481068:GTG:G | donor_gain | 0.9900 |
| 1:32481069:TGT:T | donor_gain | 0.9900 |
| 1:32481072:A:AG | donor_loss | 0.9900 |
| 1:32485339:A:T | donor_gain | 0.9900 |
| 1:32485411:T:TG | donor_gain | 0.9900 |
| 1:32465101:GGAAG:G | donor_gain | 0.9800 |
| 1:32465102:GAAGG:G | donor_gain | 0.9800 |
| 1:32465103:A:T | donor_gain | 0.9800 |
| 1:32466972:G:GG | donor_gain | 0.9800 |
| 1:32480885:CCCCA:C | acceptor_loss | 0.9800 |
| 1:32480886:CCCA:C | acceptor_loss | 0.9800 |
| 1:32480887:CCA:C | acceptor_loss | 0.9800 |
| 1:32480888:CA:C | acceptor_loss | 0.9800 |
AlphaMissense
3281 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:32480926:T:C | C343R | 1.000 |
| 1:32480935:T:C | C346R | 1.000 |
| 1:32480937:C:G | C346W | 1.000 |
| 1:32481010:T:C | C371R | 1.000 |
| 1:32481031:T:C | F378L | 1.000 |
| 1:32481032:T:C | F378S | 1.000 |
| 1:32481033:C:A | F378L | 1.000 |
| 1:32481033:C:G | F378L | 1.000 |
| 1:32485128:T:C | C400R | 1.000 |
| 1:32480926:T:A | C343S | 0.999 |
| 1:32480927:G:C | C343S | 0.999 |
| 1:32480928:T:G | C343W | 0.999 |
| 1:32480935:T:A | C346S | 0.999 |
| 1:32480936:G:A | C346Y | 0.999 |
| 1:32480936:G:C | C346S | 0.999 |
| 1:32480966:T:C | L356P | 0.999 |
| 1:32480972:G:C | R358P | 0.999 |
| 1:32480974:C:G | H359D | 0.999 |
| 1:32480976:C:A | H359Q | 0.999 |
| 1:32480976:C:G | H359Q | 0.999 |
| 1:32480980:C:A | R361S | 0.999 |
| 1:32480981:G:C | R361P | 0.999 |
| 1:32480986:C:G | H363D | 0.999 |
| 1:32480988:C:A | H363Q | 0.999 |
| 1:32480988:C:G | H363Q | 0.999 |
| 1:32481010:T:A | C371S | 0.999 |
| 1:32481011:G:A | C371Y | 0.999 |
| 1:32481011:G:C | C371S | 0.999 |
| 1:32481012:T:G | C371W | 0.999 |
| 1:32481019:T:C | C374R | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000051325 (1:32467745 A>G), RS1000105842 (1:32496481 G>C), RS1000151458 (1:32467328 C>T), RS1000279917 (1:32489405 G>A), RS1000329824 (1:32482377 A>G), RS1000534010 (1:32490771 A>T), RS1000648552 (1:32490941 G>A), RS1000660689 (1:32486484 G>A), RS1000687857 (1:32480279 G>A), RS1000717889 (1:32483558 T>C), RS1000794463 (1:32476898 C>G), RS1000846909 (1:32476501 A>C), RS1001065906 (1:32483852 C>T), RS1001084279 (1:32463772 A>G), RS1001104916 (1:32466023 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.